In a study comparing the efficacy of Degarelix alone or in a combination therapy with LHRH agonist, Goserelin, and bicalutamide, it was reported that the former produced greater urinary tract symptom relief and improved life in PCa patients [144]. This evidence concerns the gene GNRH1 and posterior cortical atrophy.